GFAP and glioblastoma: Clinical pathology tests for immunoreactive glial fibrillary acidic protein (GFAP) on tissues had been performed in 16/54 cases (30%) of GBM, 11/13 cases (85%) of AS, and 17/21 cases (81%) of ODG (data not shown).